Abstract
We describe a patient with CML in 1st chronic phase (CP) who experienced a graft failure 9 months after an HLA genotypically identical sibling BMT. Drug toxicity, viral infections, chronic graft-versus-host-disease (GVHD) or leukemic relapse were excluded. Chimerism study showed 85% of donor marrow cells. She underwent a second BMT, reengrafted but died of grade IV acute GVHD.
Vol. 83 No. 3 (1998): March, 1998 : Case Reports
Published By
Ferrata Storti Foundation, Pavia, Italy
Statistics from Altmetric.com